Abstract
Acinetobacter baumannii is a Gram-negative pathogen responsible for a variety of community- and hospital-acquired infections. It is recognized as a life-threatening pathogen among hospitalized individuals and, in particular, immunocompromised patients in many countries. A. baumannii, as a member of the ESKAPE group, encompasses high genomic plasticity and simultaneously is predisposed to receive and exchange the mobile genetic elements (MGEs) through horizontal genetic transfer (HGT). Indeed, A. baumannii is a treasure trove that contains a high number of virulence factors. In accordance with these unique pathogenic characteristics of A. baumannii, the authors aim to discuss the natural treasure trove of pan-genome and virulence factors pertaining to this bacterial monster and try to highlight the reasons why this bacterium is a great concern in the global public health system.
Keywords: Acinetobacter baumannii, genome, plasticity, virulence factors, molecular pathogenicity
1. Introduction
Acinetobacter baumannii is named after the American bacteriologists Linda and Paul Baumann. The most isolated strains of Acinetobacter spp. from clinical samples belong to A. baumannii [1]. According to the proposal of Brisou and Prévot, which was based on the results of transformation assays, the non-motile bacteria of Achromobacter were reclassified as Acinetobacter genus in 1954 [1,2].
In 1911, some surveys analyzed Acinetobacter isolates taken from the soil, which was known as Micrococcus calcoaceticus. As a new bacterial genus, Acinetobacter was officially classified in 1971 [3]. In accordance with the List of Prokaryotic names with Standing in Nomenclature (LPSN) (https://lpsn.dsmz.de/, accessed on 11 March 2024), the name Acinetobacter is rooted in the Greek language, meaning A (non-); cinet (motile); bacter (rod). With the progression of advanced high-throughput molecular technologies, 82 validly published species in association with the bacterium of Acinetobacter have been reported up to 11 March 2024 (https://lpsn.dsmz.de/genus/acinetobacter, accessed on 11 March 2024) [4].
Although the ubiquitous Gram-negative, catalase-positive, aerobic, non-fermenter coccobacilli of A. baumannii is recognized as a non-motile bacterium, it can be moved via a twitching process [3,5,6]. As a ubiquitous bacterium, A. baumannii can be recognized in different natural habitats and environments, e.g., soil and water. Due to this knowledge, this bacterium can also be isolated from non-human hosts such as arthropods (human head lice), animals and plants. In this regard, A. baumannii is known as an important pathogen among animals and in veterinary clinics [7,8].
A. baumannii is a life-threatening pathogen among hospitalized individuals and, in particular, immunocompromised patients in many countries. A. baumannii may cause serious hospital (HAIs) and community-acquired infections (CAIs), e.g., bacteremia, septicemia, severe (ventilator-associated) pneumonia, etc.
Moreover, A. baumannii is a member of the ESKAPE group. ESKAPE is an acronym for Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, A. baumannii, Pseudomonas aeruginosa and Enterobacter spp. [5,6,9,10]. As previous studies show, the ESKAPE group members are predisposed to receive and exchange the mobile genetic elements (MGEs), e.g., plasmids bearing antimicrobial resistance genes (ARGs) through horizontal genetic transfer (HGT). On the other hand, antimicrobial resistance (AMR) is a significant global concern and is placed among the top 10 worldwide threats to public health [9,10,11,12,13].
Most HAIs are caused by multidrug-resistant (MDR) strains of A. baumannii. The critical or priority 1 case of the World Health Organization (WHO) relating to the AMR problem belongs to carbapenem-resistant A. baumannii (CRAB) strains [5,9]. As previous studies show, the highest rate of multidrug-resistant (MDR) strains of A. baumannii belong to the Middle East and Europe, while the lowest rate of MDR strains of A. baumannii is associated with North America.
With the global increase of antimicrobial abuse or overuse, three groups of microbial-resistant strains, including A. baumannii-resistant strains, have appeared. These three categories are composed of MDR (resistant to the major portion of antimicrobials excluding two antimicrobials) strains, pandrug-resistant (PDR/resistant to all of the present antibiotics) strains and extensively drug-resistant (XDR/resistant to >three classes of antibiotics) strains [6].
In total, A. baumannii uses five resistant mechanisms, including the production of β-lactamase enzymes, the production of multidrug degrading enzymes, plasma membrane-related proteins’ molecular patterns’ alteration, recruitment of MDR pumps, and ribosomal methylation [6,14,15,16].
In recent years, the use of next-generation sequencing (NGS) technologies such as whole-genome sequencing (WGS) techniques has led to an effective increase in the knowledge concerning bacterial resistomes, molecular epidemiology typing and strain detection. The WGS technique enables us to screen very close strains of A. baumannii differing via a single nucleotide [5,9,17,18].
The genomic plasticity of the pathogenic strains of A. baumannii seems high; according to global reports, these pathogens possess versatile genomic sequences in different geographical areas worldwide [19,20].
The major goal of the present review literature is to highlight the main virulence factors, molecular pathogenesis and a genomic pool of CRAB strains.
2. Genomic Pool
The study of bacterial pan-genomics started about two decades ago, and the progression of advanced high-throughput technologies, e.g., NGS methodologies, has supported this effective discipline [21]. According to pan-genomic classical categorization, the bacterial genomic pool, including the A. baumannii’s genomic pool is composed of a core genome (>99%) (the softcore genome is a stable genomic pool which can be detected among 95–99% oe all strains), which contains those genes distributed among all related strains and are involved in cell division, energy production, genetic processes, metabolism, etc. In this regard, as a part of core genomic pool, the housekeeping genes are good examples because they are involved in different types of vital cellular activities, e.g., replication, gene expression, translation, etc.) [22,23,24,25,26,27,28,29,30]. The accessory genome genes (flexible, dispensable, and adaptive), which is distributed among ≥2 related strains (the subset of accessory shell genes; (detectable within 15–95% of the genomic datasets)) have contributed to adaption to niches, virulence factors and antibiotic resistance. The dispensable genes are normally acquired via HGT or an occurrence of paraphyletic evolution] [22,23,24,30,31,32], and singleton genes [unique, exclusive, cloud genes (detectable in <15% of the genomic datasets)], which are recognized in just one strain (singletons are normally acquired through the HGT feature and they are in association with effective adaptation, virulence and pathogenicity in pathogenic bacteria) [22,23,24,30,33,34,35].
The median length of A. baumannii genomes is about 3.96 Mb with a median DNA G+C content of 39% (https://www.ncbi.nlm.nih.gov/genome/?term=Acinetobacter+baumannii, accessed on 11 March 2024).
The bacterial pan-genomes can be determined to be closed or open. In this regard, by the recruitment of Heap’s formula (n = κ * N−α), in which n is the number of genes associated with a determined number of genomes, κ and α are recognized as free items that can be empirically obtained (α = 1 − γ), and N is the number of genomes. However, when α > 1, it means that a pan-genome is closed, and when α ≤ 1, it means that the pan-genome is open [22,36]. The pan-genomic structural studies show that A. baumannii possesses an open pan-genome bearing a large number of MGEs such as Insertion sequences (ISs), transposons (Tns) and integrons in genomic islands. Furthermore, A. baumannii may bear the resistance genes on a wide range of plasmids from 2 kb to >100 kb in length [37,38,39]. As the reported results indicate, the occurrence of recombination and a variety of gene exchange mechanisms may lead to the entrance of new genes into bacterial genomes like A. baumannii [6,40]. These facilities expand the genomic pool of the A. baumannii strains through the addition of new genes. In this manner, the novel genes are detectable in newly sequenced genomes pertaining to A. baumannii. The α parameter in Heap’s law regarding the pan-genome of A. baumannii equals 0.71 (0 < 0.71 < 1). This amount of α confirms that the pan-genome of A. baumannii should be open. This feature is correlated with universal high genomic plasticity among A. baumannii strains [22,31,36,41,42].
These characteristics of A. baumannii strains, including the presence of a wide range of different novel genes in different strains’ genomes of A. baumannii, which is the outcome of gene duplications or HGT via MGEs, have been shown by Rodrigues et al. [6]. As the recorded reports show, the ARGs are located in both the core and accessory genomic pool in A. baumannii. ISs, integrase and transposase enzymes, are effective means in genetic exchanges with other bacterial species and strains through HGT to add the ARGs to the A. baumannii accessory genomic pool. Hence, HGT contributes effectively to the bacterial evolution of pathogenicity and virulencity in A. baumannii. Furthermore, some plasmids were identified bearing integrated intact prophages in A. baumannii. These prophages may be integrated within the plasmids through direct integration or via recombination (with the bacterial chromosome). The acquired prophage-encoded genes in A. baumannii seem to be involved in bacterial MDR. The reported results depict effective participation of prophages in A. baumannii’s pathogenicity evolutionary pathway and its spread [43].
The ISs in Acinetobacter strains, including A. baumannii (ISAba), are key genetic elements for the activation and transmission of carbapenem-hydrolyzing β-lactamase enzymes. Indeed, the ISs are responsible for the global concern regarding A. baumannii infections in public health systems. ISs (1 kb) are known as the simplest and smallest MGEs. Therefore, ISAba elements may lead to significant genomic variability in A. baumannii strains [38,44,45,46,47,48].
As previous studies show, both ISs and Tns have the same structures and recruit transposases to be inserted within a genomic site. Tns transfer different ARGs [38,48,49]. Integrons and site-specific recombinases are other elements belonging to MGEs that contribute to acquiring resistance cassettes. The gene cassettes relate to integrons and can encode antimicrobial resistance. The gene cassettes act as small non-autonomous MGEs, normally composed of a promoter-free open reading frame (ORF) and a recombination site known as attC [38,50,51]. The miniature inverted-repeat transposable elements (MITEs) are another non-autonomous structure that is a member of MGEs. It seems that ancestral ISs and Tns are the main sources of these degraded elements. Although MITEs have no ORFs in most cases, their involvement in antibiotic resistance promotion among Acinetobacter strains is a global concern [38,52,53,54].
In addition, Rodrigues et al. [6] showed that the strains of A. baumannii possess considerable gene permutation in their genomes while they are not significantly clonal. This feature has been detected via the recognition of several gaps between the strains’ genomes through the bioinformatic genomic comparative in silico assays in bioinformatic (dry) labs [6,39,55,56,57]. Rodrigues et al. [6] detected a variety of genomic islands, including metabolic islands, pathogenicity islands (PAIs), resistance islands and symbiotic islands within the genomic pools of strains belonging to A. baumannii. The highest number of the islands were associated with resistance islands, while the lowest number was related to symbiotic islands. The identified resistance genes within the resistance islands pertaining to some enzymes and efflux pumps (Figure 1) [6,58,59]. Furthermore, blaoxa genes (including a wide range of D class β-lactamase variants) with a high diversity of variants are detectable in pan-resistome studies in association with A. baumannii [12,60,61].
The outer membrane vesicles (OMVs) are effective vehicles for transferring DNA fragments among bacterial species and strains. In this regard, the plasmid-borne genes of blaNDM-1 and blaOXA-23 and/or free environmental DNA molecules ((e-DNAs), whether via bacterial cell lysis or type VI secretion system (T6SS)) can be transferred from an A. baumannii strain to another through the OMVs. In recent years, it has been reported that chromosomal ARGs can be transferred between A. baumannii strains via the phage-mediated HGT. Therefore, the transmission of ARGs, e.g., blaNDM-1, can occur via generalized phage transduction among the MDR strains of A. baumannii instead of direct cell–cell interaction. In addition, phages are suitable vehicles for transferring genomic DNA fragments bearing ARGs between MDR strains of A. baumannii [66]. As recent investigations show, prophages are significant cargo capable of encoding ARGs in their bacterial hosts (A. baumannii strains). This feature may support the occurrence of lysogenization as a pivotal feature in phage-mediated HGT [67]. The most frequent feature pertaining to colistin resistance in A. baumannii is the occurrence of mutations in chromosomal operon genes of pmrCAB. However, it has been most recently observed that the colistin resistance feature can be transduced even by the A. baumannii bacteriophage of Φ19606 through the transmission of the eptA1 gene (the homolog of pmrC gene) via the HGT. Up until now, the A. baumannii bacteriophage of Φ19606 is the first phage-mediated colistin resistance feature in bacterial cells [62].
3. Virulence
3.1. Virulence Factors and Molecular Pathogenesis
Through a wide range of pan-genomic studies, it has been recognized that A. baumannii is an open pan-genomic bacterial pathogen; hence, A. baumannii encompasses a variety of virulence factors with different functions and activities. Because of the importance of these virulence factors, Table 1 shows a complete package of the identified virulence factors together with the related genes [3,68,69].
Table 1.
Virulence Factors | Functions |
---|---|
Capsule (CPS) | Antimicrobial resistance, host–pathogen interactions and pathogenesis |
Efflux pumps | Antimicrobial resistance, biofilm formation, disinfectant resistance, heavy metal resistance and response to oxidative and osmotic stresses |
Lipopolysaccharide (LPS) | Antimicrobial resistance, bacterial motility and induction of pro-inflammatory cytokines in humans |
Lipooligosaccharide (LOS) | Antimicrobial resistance, bacterial adhesion, resistance to human opsono-phagocytosis and induction of pro-inflammatory cytokines in humans |
Outer membrane proteins (OMPs) | Antimicrobial resistance, induction of apoptosis in human cells, bacterial adhesion, invasion and dissemination, cytotoxicity in human cells, host–pathogen interactions, induction of reactive oxygen species (ROS) in human cells, metal ion acquisition and substrate translocation |
Pili | Bacterial adhesion, bacterial attachment (irreversible), biofilm formation, genetic exchange through HGT and motility (e.g., twitching) |
Metal ion uptake systems | Bacterial metal (e.g., Zn, Fe, Mn) uptake, translocation, metabolism homeostasis, biofilm formation, quorum sensing regulation and response to oxidative stress |
Two-component systems (TCSs) | Antimicrobial resistance, aromatic compound metabolism, bacterial pathogenesis, biofilm formation, capsule expression, regulation of bacterial motility, lipid A modification, regulation of some groups of efflux pumps and resistance to human serum |
Secretion systems (SSs) | Antimicrobial resistance, bacterial adhesion, biofilm formation, bacterial colonization and proliferation within the human cells, bacterial survival, enzyme and toxin secretion, induction of apoptosis in human cells, genetic elements exchange via HGT and pathogenesis |
In accordance with the latest studies, the deciphered virulence and pathogenesis factors in A. baumannii are divided into nine groups, including capsular exopolysaccharide (CPS), efflux pumps, lipopolysaccharide (LPS), lipooligosaccharide (LOS), outer membrane proteins (OMPs), pili, metal ion uptake systems, two-component systems (TCSs) (virulence factors’’ regulators), and secretion systems (SSs) (Figure 1 and Figure 2) [68]. These items are summarized in Table 1.
In recent years, pan-genomic investigations indicated that the majority of virulence factors and ARGs are transmitted via different MGEs, including Tns, ISs, integrons, bacteriophages, etc. Many of these MGEs are transferred by a mass of plasmids through different types of HGT [66,67,70]. Table 2 indicates the related items.
3.2. Capsular Exopolysaccharide (CPS)
CPS is known as the main virulence factor arming A. baumannii stains. This structure acts as a superficial multifunctional virulence factor that pathogenic bacteria like A. baumannii use to survive in unfavorable environmental conditions, such as the presence of antimicrobials, human host cell immune defense mechanisms and prolonged desiccation (Table 2) [68,71,72]. The omission of CPS expression in CPS-producing A. baumannii strains may significantly affect bacterial virulency and pathogenesis.
Indeed, CPS is recognized as a pivotal protection for bacterial survival in vivo (Figure 1 and Figure 2) [73]. CPS is composed of repeating K units; however, the K units differ in composition, length and structure (branched or unbranched). The results reported by analytical investigations show that K units are constructed by derivatives of simple UDP-linked sugars. These sugar molecules are mainly comprised of glucose and galactose and sometimes form complex sugars, e.g., non-2-ulosonic acid. This diversity among K units depicts the presence of effective variabilities (>100 different types) in capsular loci. Moreover, the structure of K units directly determines the virulence and pathogenesis of A. baumannii strains [71,72,74,75]. Those genes between fkpA and lldP genes encode proteins involved in capsular polysaccharides biosynthesis and/or transmission processes [74]. The two-component system (TCS) of BfmRS is involved in the upregulated expression of K loci and increased capsule secretion [71,76].
3.3. Efflux Pumps
Efflux pumps are important bacterial defensive mechanisms that support bacterial pathogens, e.g., A. baumannii strains, in the presence of antimicrobial drugs. The efflux pumps extrude the antimicrobials from the exposed bacteria. Although A. baumannii encompasses effective structures of outer membranes (OMs) with low permeability against the large-sized molecules of antimicrobial drugs, the efflux pumps have a vital role in this regard (Figure 1). Because of the wide varieties of efflux pumps in different prokaryotic cells of bacteria, these pumps are categorized into six different groups, including the ATP Binding Cassette (ABC), Small Multidrug Resistance (SMR), Major Facilitator Superfamily (MFS), Proteobacterial Antimicrobial Compound Efflux (PACE), Multidrug And Toxic compound Extrusion (MATE), and Resistance Nodulation Division (RND). The identified efflux pumps among the A. baumannii isolates are shown in Table 2 and Figure 2. Some members of RND may also be involved in biofilm formation [77,78,79,80]. The MFS group possesses the widest range of varieties and, therefore, is present in different types of life domains. The MFS transporters are classified into three categories called antiporters, symporters and uniporters [68,80,81].
In accordance with reported results from different studies, the efflux pumps pertaining to RND family members may be responsible for the appearance of intrinsic resistance among Gram-negative bacteria, including A. baumannii strains, in exposure to a wide range of antimicrobial groups [80,81,82]. AdeABC is known as the first member of the RND efflux pump, which was detected in clinical isolates of A. baumannii strains. The AdeABC contributes to bacterial resistance against various antimicrobial groups, e.g., β-lactams, chloramphenicol, aminoglycosides, fluoroquinolones, erythromycin, and so on. Moreover, this member of RND is increasingly produced among MDR strains isolated from clinical samples. Hence, AdeABC may be identified as the most clinical-related RND efflux pump [68,79,80,82,83]. The efflux pumps contribute to other vital bacterial activities rather than MDR characteristics, including virulence, surface-related motility, quorum sensing activities and the related pathways, e.g., biofilm formation (Figure 1 and Figure 2) [84,85].
3.4. Lipopolysaccharide (LPS)
LPS is the main molecule that forms the OM in Gram-negative bacteria. The structural integrity of the OM is covered by the LPS composition through their presence in high abundance. It also determines the permeability capabilities of bacterial OM in exposure to hydrophobic molecules. The LPS (smooth LPS) molecule is composed of three segments: lipid A (a glycolipid), a core (made up of oligosaccharide) and a repetitive O-antigen (an effective immunogen structure) (Figure 1 and Figure 2). The core bridges lipid A to the O-antigen. These properties of LPS make it a microbe-associated molecular pattern (MAMP) for human host innate and adaptive immune system components such as toll-like receptors (TLRs) [3,87,88,89,90,91,92,93]. TLRs and interleukins (ILs) are important immune biomolecules that can be induced by stranger molecules, such as different parts of microbial components. TLR activation may lead to induce TLR signaling pathways that results in activation of several immune cells and immune biomolecules in a cascade process. In this regard, the LPS of A. baumannii triggers the production of a cascade of biomolecules such as pro-inflammatory cytokines (e.g., IL-8, tumor necrosis factor-α (TNF-α), CCL4, TLR4, etc.) [3,87,92,93,94]. The lipid A, as a negatively charged component of the LPS biomolecule, makes the bacterial cells of A. baumannii susceptible to the cationic polypeptide of colistin. The lpxABCD gene operon encodes the LPS components (Table 2) [68,95].
3.5. Lipooligosaccharide (LOS)
LOS, which is known as rough LPS, misses the immunogenic component of the O-antigen within its structure (Table 2) [91]. The high-variated oc locus is usually identified in Gram-negative bacteria, e.g., A. baumannii. The oc locus is located in the region between ilvE and aspS genes. The early detection of OCL1–3 variants was achieved in a genomic pool of A. baumannii. The biomolecule of LOS contributes to a wide range of activities, including induction of pro-inflammatory immune responses (as aforementioned in association with LPS), bacterial motility, killing-resistant activity against opsono-phagocytosis, superficial attachment, bacterial susceptibility in exposure to colistin as a polymyxin antimicrobial agent and resistance to serum antimicrobial peptides in the human body [95,96,97,98,99,100,101,102,103,104,105,106,107].
3.6. Outer Membrane Proteins (OMPs)
OMPs are important bacterial virulence factors in A. baumannii strains for bacterial adherence in the human host cells (Table 1 and Table 2, Figure 2). OmpA contributes to bacterial adhesion (A. baumannii ATCC17978 and ATCC19606) to the epithelial cells [69]. OmpA is capable of attaching to human host integrins, junctional adherence proteins, fibronectin and cytoskeleton. In the AB5075 strain of A. baumannii, the OmpA binds to desmosomes and hemidesmosomes to modulate the processes of cell-to-cell contact in epithelial cells and weakening cell-to-cell interactions. This strategy helps the bacterial cells of A. baumannii to invade the epithelial cells of the host body. Therefore, the overexpression of OMPs in A. baumannii is presumed to be an effective means for bacterial adhesion to human host cells as a part of bacterial virulence and pathogenesis [69,108,109].
Although OMPs in Gram-negative bacteria are located within the bacterial OM, they participate in different types of bacterial activities, including bacterial adhesion and invasion, biofilm formation, occurrence of antibiotic resistance to a wide range of antibiotic families, host-mediated stresses, bacterial survival and induction of apoptosis (programmed cell death) through the activation of caspase enzymes within the human host cells [57,110,111,112,113]. In addition to OmpA, OmpW, Omp33–36, outer membrane carboxylate channels (Occ) and Carbapenem susceptible protein (CarO) are the pivotal OMPs involved in bacterial virulence and pathogenesis of A. baumannii (Table 2) [68].
The highest portion of porins in A. baumannii belongs to OmpA. This porin is composed of two domains: an N-terminal (made up of an eight-stranded antiparallel β-barrel) situated within the OM and a C-terminal with a globular configuration interacting with the bacterial cell wall. OmpA induces TLR2 in epithelial cells of the lung human host and promotes the permeability of the lung epithelial cells [110,111,114,115,116,117]. A major portion of OmpA can be transferred into the human host cells through the OMVs, produced by the bacterial cells of A. baumannii. The OmpA molecules enter the human host cells through the fusion process of OMVs [118].
OmpW encompasses an eight-stranded antiparallel β-barrel configuration located in OM. It participates in bacterial adhesion, invasion, biofilm formation and iron acquisition. As the reports show, the TCS of BfmRS regulates the expression of the OmpW encoding gene and those genes that contribute to the expression of siderophores and oxidative osmotic stress response [119,120,121,122].
CarO is another member of OMPs involved in the carbapenem resistance feature and acquisition of some amino acids, e.g., glycine and ornithine, in A. baumannii strains (Table 1). As previously mentioned, CarO contributes to bacterial adhesion, dissemination and invasion into the human host cells, such as lung epithelial cells [123,124,125].
Occ proteins form channels with narrow pore sizes. Occ proteins are structured as monomeric 18-stranded β-barrels, participating in small molecule transmission. Five orthologs of these proteins, including OccAB1, OccAB2, OccAB3, OccAB4 and OccAB5, have been detected in A. baumannii ATCC17978. OccAB1 or former OprD belongs to Occ family proteins in Pseudomonas aeruginosa. Although OprD contributes to carbapenems acquisition in bacterial cells of P. aeruginosa, OccAB1 has no relationship with carbapenem acquisition in bacterial cells of A. baumannii. Recently, a new homolog of OprD has been detected in clinical isolates of A. baumannii, which is related to hypervirulence in CRAB strains [13,126,127,128,129,130].
The Omp33–36 protein in A. baumannii strains is involved in bacterial adhesion, invasion, cytotoxicity and resistance to carbapenems. In contrast to OmpA, which encompasses nuclear localization signals to induce the apoptosis feature in host cells, the Omp33–36 protein does not express this feature. However, the internalized Omp33–36 is able to activate the caspase enzymes to induce apoptosis feature in host cells [131].
3.7. Pili
Pili are known as pivotal structures in pathogenic bacteria for bacterial adherence to biotic (human host cells) or abiotic (catheter) surfaces to have effective pathogenesis and infection (Table 1). Indeed, these superficial, short, antigenic thread-like appendages are detectable in both Gram-negative and Gram-positive bacteria categories. Because of the high diversity of pili in Gram-negative bacteria, they have been categorized into five different groups: chaperone-usher pili (CUP), curli fimbriae, type IV pili, type V pili, and conjugative type IV secretion pili (Table 2). The CUP pili are effective virulence factors in clinical isolates of A. baumannii strains because of their capability to adhere to biotic and abiotic surfaces in human patients with different infectious diseases like urinary tract infections [69,132,133]. The immunogenic Csu pili (Figure 2) belongs to type I CUP and has been detected in A. baumannii strains. These pili are involved in bacterial attachment to hydrophobic (tight adhesion) and hydrophilic (very loose adhesion) surfaces but not to the epithelial cell line surfaces [84,132,134,135].
On the other hand, type IV pili in the bacterial cells of A. baumannii are involved in twitching, superficial adhesion, biofilm formation and natural transformation (Figure 2). These pili activities are regulated by the GacSA TCS. The PilA variants have different activities in oppose to surface chemistry [136,137,138,139,140]. Curli fibers (Table 2) are constructed by different types of Csg pilins. Although curli fimbriae are detected in some strains of E. coli, no report has been recorded in association with a complete machinery system of curli biosynthesis in A. baumannii [132,141].
3.8. Metal Ion Uptake Systems
Metal ion uptake systems are vital means for pathogenic bacteria like A. baumannii to survive (Table 1). In this regard, metal ions associated with iron, zinc and manganese are essential elements for eukaryotic host cells, e.g., human host cells and microbial pathogens such as A. baumannii. On the one hand, iron, as an important metal ion, is restricted through employing associated proteins, including hemoglobin (the major protein), ferritin, lactoferrin, transferrin and calprotectin (a metal-chelating antimicrobial protein pertaining to the innate immune system) by the human host cells. On the other hand, pathogenic bacteria like A. baumannii have their own iron acquisition systems, e.g., siderophore proteins (e.g., three classes of acinetobactin, baumannoferrin, and fimsbactin) and heme acquisition systems (Table 2) [142,143]. The enzyme phospholipase C, produced by bacterial cells of A. baumannii, disrupts the human host red blood cells (RBCs) to uptake the released hemoglobin. Then, the bacterial heme acquisition system converts the released form of the iron ion into the requisite form for bacterial cells. The bacterial heme acquisition system is a multi-sectional and multi-functional system. In this regard, the heme oxygenase component is responsible for converting ferrous ions (Fe3+) into ferric ions (Fe2+) [144,145,146,147].
Siderophore activity needs energy produced via the proton motive force (pmf) situated across the bacterial inner membrane. Furthermore, this process is modulated by a protein complex composed of TonB-ExbB-ExbD and ABC transporters. The expressed siderocalin molecules by neutrophils prevent the iron acquisition activity of the bacterial siderophores [68,76,142,147]. As published reports show, the evolution of iron acquisition systems in A. baumannii can be occurred through different genetic exchanges, e.g., HGT [148]. Zinc is another important metal essential for both human host and bacterial pathogens, e.g., A. baumannii. Bacterial enzymes like metalloproteins need zinc for their activity. The overexpression of znuABC genes by A. baumannii to acquire further zinc ions from the environment is modulated by the zinc uptake regulator (Zur), a zinc-binding protein about the ferric uptake regulator (Fur) protein family [149,150,151,152].
Metal ions of Manganese (Mn2+) play a key role as co-factors in a wide range of enzymes, such as superoxide dismutase, which contributes to protecting bacterial cells of A. baumannii from reactive oxygen species (ROS) in the feature of oxidative stress. A. baumannii strains recruit natural resistance-associated macrophage protein (NRAMP) family proteins like MumT to cover themselves against the human host immunoprotein of calprotectin. MumT is a transporter enzyme that participates in manganese and urea metabolisms [153,154]. As the reported results show, a pathogen like A. baumannii needs a rigorous regulatory mechanism for its metal uptake systems and homeostasis for successful virulence and pathogenesis within the human host body [76].
3.9. Two-Component Systems (TCSs)
TCSs are pivotal systems that control the phenotypic switching processes. Due to this fact, these signal transduction systems can be detected in both archaea and bacteria. The importance of TCSs lies in their contribution to bacterial adaptation and sensing in exposure to different environmental factors and situations. A TCS is normally comprised of two components: a cytoplasmic membrane-bound sensor (e.g., a histidine kinase) and a response regulator, which is involved in DNA-binding and transcription processes. It seems that a bacterial genome may bear between 50 and 60 genes that encode TCS proteins. According to previous reports, A. baumannii strains encompass up to 20 TCSs with different functions. TCSs are able to change the bacterial genetic reactions in exposure to environmental factors, e.g., antibiotic resistance, virulency and pathogenesis (Table 2) [68,76,77,155,156].
3.10. Secretion Systems (SSs)
SSs are known as the major virulence factors because they can transfer bacterial virulence factors to the outside of the bacterial cells. This strategy induces the human host immune system and may support the virulencity and pathogenesis of pathogens like A. baumannii. Until now, six SSs—including T1SS–T6SS—have been discovered in Gram-negative bacteria such as A. baumannii. These SSs have their own compositions, functional activities, structures and roles in bacterial virulence, pathogenesis and antimicrobial resistance (Table 2, Figure 1 and Figure 2) [86].
Table 2.
Structures | Virulence Genes | Gene Position | Virulence Factors | Roles | References | |
---|---|---|---|---|---|---|
Capsule (CPS) | >100 unique capsule loci (KL) with different sizes in length (between 20 and 35 kilobases (kb)) | Between the fkpA and lldP genes on the chromosome | Capsular biosynthesis and export | Bacterial pathogenicity, Virulence, Antimicrobial resistance, Persistence, Evasion of host immune system (antiphagocytosis), reduction of interactions between human host and pathogen | [3,64,68,71,74,157] | |
Efflux pumps | ATP binding cassette (ABC) transporter | A1S-0536 | Chromosome | A1S-0536 | Resistance to erythromycin | [3,68,79,80] |
A1S-1535 | A1S-1535 | Resistance to chloramphenicol and gentamicin | ||||
abuO | AbuO | Response to oxidative stress | ||||
macAB-tolC | MacAB-TolC | Potentially resistance to macrolides and tigecycline | ||||
Multidrug and toxic compound extrusion (MATE) | abeM | AbeM | Resistance to fluoroquinolones and disinfectants | [3,6,68,79,80] | ||
Major facilitator superfamily (MFS) | abaF | Chromosomal genomic islands | AbaF | Resistance to fosfomycin | [3,68,79,80,158] | |
abaQ | AbaQ | Resistance to quinolones | ||||
amvA | AmvA | Resistance to erythromycin | ||||
cmlA | CmlA | Resistance to chloramphenicol | ||||
craA | CraA | Resistance to chloramphenicol | ||||
emrAB | EmrAB | Resistance to colistin and adaptation to osmotic stress | ||||
tetA | Plasmids and MGEs | TetA | Resistance to tetracycline and tigecycline | |||
tetB | TetB | Resistance to minocycline and tetracycline | ||||
Resistance nodulation division (RND) | abeD | Chromosome | AbeD | Resistance to benzalkonium chloride, ceftriaxone, gentamicin, rifampin, tobramycin, killing the host cells | [3,6,65,74,75,76,77] | |
acrAB | AcrAB | Resistance to disinfectants, colistin and tobramycin | ||||
adeABC | AdeABC | Resistance to aminoglycosides, chloramphenicol, fluoroquinolones, pentamide, tetracyclines, trimethoprim and osmotic stress | ||||
adeDE | AdeDE | Resistance to chloramphenicol, erythromycin, tetracycline, amikacin, meropenem, ceftazidime, rifampin and ciprofloxacin | ||||
adeFGH | AdeFGH | Resistance to clindamycin, chloramphenicol, fluoroquinolones, tetracycline-tigecycline and trimethoprim, biofilm formation | ||||
adeIJK | AdeIJK | Resistance to erythromycin, β-lactam antibiotics, trimethoprim, tetracycline, fusidic acid, chloramphenicol, novobiocin, lincosamides and rifampin | ||||
adeL | AdeL | Resistance to fluoroquinolones and tetracycline | ||||
adeN | AdeN | Resistance to macrolides, tetracycline, cephalosporins, carbapenem, penems, fluoroquinolones and rifamycin | ||||
adeXYZ | AdeXYZ | Similar to AdeIJK in phenotypic, structural and genetic characteristics (homologs) | ||||
arpAB | ArpAB | Resistance to tobramycin and amikacin | ||||
czcABCD | CzcABCD | Resistance to heavy metals, e.g., copper | ||||
Proteobacterial antimicrobial compound efflux (PACE) | A1S-1503 | Chromosome | A1S-1503 | Resistance to disinfectants | [3,68,79,80] | |
aceI | AceI | Resistance to disinfectants | ||||
Small multidrug resistance (SMR) | abeS | Chromosome | AbeS | Resistance to novobiocin, erythromycin, chloramphenicol, fluoroquinolones and disinfectants | [3,68,79,80] | |
qacE | QacE | Resistance to disinfectants | ||||
Lipopolysaccharide (LPS) | lpxACD operon; lpxB | Chromosome, plasmids | lipidA biosynthesis, LPS biosynthesis | Bacterial surface-associated motility, Microbe associated molecular pattern (MAMP), Immune system activation through triggering the expression of versatile pro-inflammatory cytokines, e.g., toll-like receptor 4 (TLR4), interleukin 8 (IL-8), Tumor necrosis factor-α (TNF-α) and CCL4, Bacterial susceptibility against colistin | [62,87,94,98,159,160] | |
Lipooligosaccharide (LOS) | Outer core (OC) loci (OCL) | Between ilvE and aspS genes on the chromosome | lipid-carbohydrate surface structure | Antimicrobial peptides resistance, Bacterial adhesion, Bacterial resistance against human host opsonophagocytotic activities, bacterial cell motility, Induction of expression of several pro-inflammatory cytokines | [3,96] | |
Outer membrane proteins (OMPs) | carO | Chromosome, plasmids | CarO | Resistance to Carbapenems, uptake of glycine, imipenem, and ornithine, contribution to bacterial adhesion, invasion and dissemination | [3,68,77,119,125,161] | |
occAB1–AB5 | OccAB1–AB5 | Substrates translocation, metal ions acquisition, e.g., iron (Fe2+) and magnesium (Mg2+), antibiotics (β-lactams) and amino acids uptake, participation in nutritional immunity and stress survival caused by the host (host–pathogen interactions) | ||||
omp33–36 | Omp33–36 | Resistance to carbapenems, activation of caspase enzymes of 3 and 9 and apoptosis within the host cells, cytotoxicity, bacterial adhesion and invasion into the host’s epithelial cells | ||||
ompA | OmpA | Resistance to β-lactams and colistin, iron siderophores (e.g., acenitobactin) acquisition, cytotoxicity, bacterial adhesion through fibronectin (irreversible attachment), invasion and persistence, induction of reactive oxygen species (ROS) and apoptosis within the host cells, it has been recognized in up to 81% of isolated strains of A. baumannii | ||||
ompW | OmpW | Bacterial adhesion and invasion into pulmonary epithelial cell lines, cytotoxicity, iron acquisition | ||||
Pili | Chaperon-usher type I pili | csuA/BABCDE | Plasmid/chromosome | Formation of chaperone-usher Csu fimbriae; CsuA/B (Shaft of the pili (Major subunit)), CsuA (Minor subunit), CsuB (Minor subunit), CsuC (Chaperon), CsuD (Usher), CsuE (Adhesin tip) |
Biofilm formation on abiotic surfaces, irreversible attachment; recognized in up to 100% of the isolated strains belonging to A. baumannii | [68,77,162,163] |
Type IV pili |
pilApgyA, pilBCD, pilTU |
Plasmid/chromosome | Formation of type IV pili; PilA (Major subunit), PgyA (O-glycosylase), PilB (putative traffic ATPase), PilC (putative inner membrane platform protein), PilD (putative prepilin peptidase), PilT (putative retraction ATPase), PilU (putative retraction ATPase) |
Biofilm formation, host-cell adhesion, twitching motility, HGT, microcolony formation |
[77,139,164] | |
Curli fiber |
csgBAC
csgDEFG |
Amyloid protein (composed of major subunits of csgA) | Adherence, matrix formation, biofilm maturation; recognized in up to 70% of the isolated strains belonging to A. baumannii | [77,165] | ||
Type I fimbriae | fimBEAICDFGH | Chromosome | FimH (adhesin) | Bacterial cell adhesion (irreversible attachment), recognized in up to 50% of the isolated strains belonging to A. baumannii | [77,165] | |
P fimbriae | papIBAHCDJKEFG | PAIs/chromosome | PapG (adhesin) | Biofilm formation (homologous to Escherichia coli); recognized in up to 80% of the isolated strains belonging to A. baumannii | [77,165] | |
Metal ion uptake systems | Phospholipase | plc1, plc2 | Plasmid/chromosome | Phospholipase C | Red blood cell lytic and hemoglobin releasing enzyme, iron uptake and lipolytic activity | [3,68] |
pld1, pld2, pld3 | Phospholipase D | iron uptake and lipolytic activity | [3] | |||
Acinetobactin (including three gene clusters of A1S-2392-A1S_2372) | basAB, basCD, basFG, basHIJ | Plasmid/chromosome | BasA–J | Biosynthesis of acinetobactin for iron uptake, persistence of the infection within the epithelial cell and apoptosis | [3,68,147,148,153,166] | |
barA, barB | BarAB | Members of siderophore efflux system of the ABC superfamily, which secrete the produced acinetobactin via bas gene clusters | ||||
bauABECD, bauF | BauA–F | Receptor for complexes of ferric-acinetobactin to translocate these complexes into the bacterial cell of A. baumannii, persistence of the infection within the epithelial cell and apoptosis | ||||
Baumanoferrin (including one gene cluster of A1S_1647-A1S-2372) |
bfnABCDEFGHIJKL | BfnA–L | Biosynthesis, translocation and the uptake of iron | |||
Fimsbactins (including two gene clusters of A1S-2582-A1S_2562) | fbsABCDEFGHIJKLMNOPQ | FbsA–Q | Biosynthesis, translocation and the uptake of iron | |||
mum operon | mumRTLUHC | MumR–C | MumR contributes to oxidative stress resistance and regulating of Mn homeostasis; MumT participates in Mn chelating, it also acts as Mn and urea transporter | |||
Fur | fur | Fur | Transcriptional regulator of iron metabolism | |||
Zinc uptake system | zigA | ZigA | Zinc homeostasis, | |||
znuBC, znuA, znuD, znuD2 | ZnuB (inner membrane channel), ZnuC (ATPase), ZnuA (periplasmic binding protein), ZnuD (outer membrane channel), ZnuD2 (outer membrane channel) | Zinc acquisition, homologous to ZnuABC system in E. coli, pathogenesis | ||||
zur | Zur | Transcriptional regulator of zinc metabolism | ||||
Two-component systems (TCSs) | A1S_2811 | A1S_2811 | Plasmid/chromosome | A1S_2811 | Hybrid sensor kinase, involved in motility (via flagella or pili), contribution to biofilm formation, regulation of quorum sensing | [155] |
AdeRS | adeRS | AdeR, AdeS | Involved in antibiotic susceptibility in A. baumannii, contribution to controlling the expression of ~600 genes (involved in, e.g., biofilm formation, multidrug-efflux activity (such as AdeABC) and virulence), directly or indirectly. | [76,155] | ||
BaeSR | baeSR | BaeS, BaeR | There is a homology between this TCS in A. baumannii and E. coli, triggered by sucrose, regulation of overlapping regulons relating to other present TCSs in A. baumannii, BaeSR may occur cross-talk with the other members of TCSs; it regulates the expression of AdeABC, ADEIJK, MacAB-TolC drug efflux pumps, Susceptible to tannic acid, contributes to bacterial antibiotic resistance |
[76,155] | ||
BfmRS | bfmRS | BfmR, BfmS | This TCS (recognized in up to 92% of isolated strains of A. baumannii) is a type of sensor kinase that regulates the expression of csu operon (pili) in A. baumannii, contribution to biofilm formation (irreversible attachment), regulation on capsule production through controlling the exopolysaccharide biosynthesis (expression of K locus), regulation of bacterial TCSs and virulence in A. baumannii, BfmS phosphorylates the BfmR | [76,77,155] | ||
GacSA | gacSA | Transposon/chromosome | GacS, GacA | Regulation of ~680 genes in association with motility, pili formation, biofilm formation, bacterial resistance towards human serum, immune evasion, catabolism of aromatic compounds (paa operon, which has homology to E. coli), bacterial pathogenesis | [76,155] | |
PmrAB | pmrAB | Plasmid/chromosome | PmrA, PmrB | Lipid A modification, contribution to colistin and polymyxin B resistance (via gene mutations) | [155] | |
Secretion system | T1SS |
tolC-hlyB-hlyD gene cluster (homologous to E. coli) |
Chromosome | TolC (a trimeric outer membrane protein interacting with HlyD), HlyB (an ATP-binding cassette transporter that provides the required energy), HylD (a periplasmic adaptor) | T1SS has cross-talk with T2SS and T6SS, Contribution to virulence, secretion of putative effectors, e.g., RTX-serralysin-like toxin and Bap and other effectors such as glycosidases, proteases, phosphatases and invasins which are involved in bacterial attachment, invasion, biofilm formation and pathogenesis | [68,86,167] |
T2SS | gspC-M, pilD | gsp genes dispersed into five clusters within the bacterial genome | GspC (a subunit of the inner membrane (IM) platform), GspD (an outer membrane (OM) complex), GspE (cytoplasmic ATPase), GspF (a subunit of the inner membrane (IM) platform), GspG-K (subunits of the periplasmic pseudopilus (GspG is known as major pseudopilin, while the others are recognized as minor pseudopilins)), GspL (a subunit of the inner membrane (IM) platform), GspM (a subunit of the inner membrane (IM) platform), PilD contributes to processes of cleavage and methylation | Secretion of enzymes and toxins such as CpaA protease, intimin-invasin lipoprotein of InvL and lipases of LipA, LipAN and LipH, pathogenesis, antibiotic resistance (e.g., resistance against ciprofloxacin) | ||
T4SS (type F) | traA-I, traK-N, traU-W, trbC, finO | Plasmid | TraA (constitutes the extracellular section of the pilus), TraB (constitutes the IM platform of the T4SS), TraC (the cytoplasmic subunit of the T4SS), TraD (the cytoplasmic subunit of the T4SS), TraE, TraF (constitutes the IM platform of the T4SS), TraG (constitutes the IM platform of the T4SS), TraH (constitutes the OM core complex of the T4SS), TraI (contributes to nick), TraK (constitutes the OM core complex of the T4SS), TraL, TraM (participates in translocation initiation), TraN (constitutes the OM core complex of the T4SS), TraU (constitutes the IM platform of the T4SS), TraV (constitutes the OM core complex of the T4SS), TraW (constitutes the IM platform of the T4SS), TrbC (constitutes the IM platform of the T4SS), FinO (regulator) | T4SS is involved in DNA exchanges, e.g., HGT features such as transformation, conjugation which may lead to translocation of virulence genes, drug-resistance genes among bacterial cells, contribution to bacterial pathogenesis, colonization and proliferation within the eukaryotic host cells | [3,68,86] | |
T5bSS | cdiA, cdiB, abfhaB, abfhaC | Chromosome | CdiA (toxin), CdiB (OM transporter) | Lethal proteins | [3,68,86] | |
AbFhaB, AbFhaC | Adhesion (via fibronectin) to host cell, virulence, bacterial survival, biofilm formation | |||||
T5cSS The most popular T5SS in A. baumannii |
ata | Chromosome | Ata | Autotransporter, biofilm formation, attachment to laminin and different types of collagens including I, III, IV and V, bacterial survival, bacterial invasion to host cells, induction of apoptosis (programmed cell death) process within the host cells | [3,68,86,112] | |
T6SS |
asaA-tssBC-hcp(tssD)-tssEFG-asaB-tssM-tagFN-asaC-tssHAKL-asaDE
vgrG-paar |
Plasmid/chromosome | TssA–M forms the core, and TagD–L constructs the accessory proteins of the T6SS structure TssL–M and TssJ form the membrane complex of the T6SS within the periplasmic space; TssE–G, TssK, VgrG and PAAR construct the cytoplasmic baseplate; TssA–C and Hcp (TssD) form the tail tube or sheath complex of the bacterial T6SS in A. baumannii |
Bacterial virulence factor, pathogenicity factor in eukaryotic host cells, bacterial invasion and adhesion, antibiotic resistance | [86,168,169] |
4. Conclusions
A. baumannii possesses a wide range of virulence factors with versatile abilities. Simultaneously, this pathogenic bacterium is supported by a significantly high plasticity in its pan-genome. In addition, A. baumannii exploits the HGT as an effective genetic exchange to acquire or transfer MGEs. These data and information reveal that despite the presence of a huge volume of pathogenicity in A. baumannii, we can also utilize this bacterial arsenal to protect ourselves against its global concern associated with public health systems worldwide. In this regard, we can find the related bacterial strategies and mechanisms to acquire different types of virulence factors and ARGs from different sources. By knowing these strategies and related resources, we can protect ourselves against their pathogenesis, dissemination, proliferation, antibiotic resistance, and transmission. Moreover, deciphering the different roles of bacterial cells and their components in induction of different immune system signaling pathways, mediators, modulators in human and non-human hosts provides us an opportunity to promote our capability against a versatile of infections caused by A. baumannii through a wide range of alternatives like new strategies in pharmaceutical therapies, immunotherapies and vaccine production.
Author Contributions
All authors have equally contributed to the conception and design of the work. All authors have read and agreed to the published version of the manuscript.
Institutional Review Board Statement
Not applicable.
Informed Consent Statement
Not applicable.
Conflicts of Interest
The authors declare no conflicts of interest.
Funding Statement
This research received no external funding.
Footnotes
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
References
- 1.Bouvet P.J., Grimont P.A. Taxonomy of the genus Acinetobacter with the recognition of Acinetobacter baumannii sp. nov., Acinetobacter haemolyticus sp. nov., Acinetobacter johnsonii sp. nov., and Acinetobacter junii sp. nov. and emended descriptions of Acinetobacter calcoaceticus and Acinetobacter lwoffii. Int. J. Syst. Evol. Microbiol. 1986;36:228–240. [Google Scholar]
- 2.Juni E., Heym G.A. Transformation assay for identification of psychrotrophic achromobacters. Appl. Environ. Microbiol. 1980;40:1106–1114. doi: 10.1128/aem.40.6.1106-1114.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Sarshar M., Behzadi P., Scribano D., Palamara A.T., Ambrosi C. Acinetobacter baumannii: An ancient commensal with weapons of a pathogen. Pathogens. 2021;10:387. doi: 10.3390/pathogens10040387. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Meier-Kolthoff J.P., Carbasse J.S., Peinado-Olarte R.L., Göker M. TYGS and LPSN: A database tandem for fast and reliable genome-based classification and nomenclature of prokaryotes. Nucleic Acids Res. 2022;50:D801–D807. doi: 10.1093/nar/gkab902. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Ali A., Khatoon A., Mirza T., Ahmad F. Intensification in Genetic Information and Acquisition of Resistant Genes in Genome of Acinetobacter baumannii: A Pan-Genomic Analysis. BioMed. Res. Int. 2022;2022:3186343. doi: 10.1155/2022/3186343. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Rodrigues D.L.N., Morais-Rodrigues F., Hurtado R., Dos Santos R.G., Costa D.C., Barh D., Ghosh P., Alzahrani K.J., Soares S.C., Ramos R. Pan-resistome insights into the multidrug resistance of Acinetobacter baumannii. Antibiotics. 2021;10:596. doi: 10.3390/antibiotics10050596. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Rafei R., Hamze M., Pailhoriès H., Eveillard M., Marsollier L., Joly-Guillou M.-L., Dabboussi F., Kempf M. Extrahuman epidemiology of Acinetobacter baumannii in Lebanon. Appl. Environ. Microbiol. 2015;81:2359–2367. doi: 10.1128/AEM.03824-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Castillo-Ramírez S. The importance of Acinetobacter baumannii from non-human sources. Lancet Microbe. 2023;4:e761–e762. doi: 10.1016/S2666-5247(23)00246-X. [DOI] [PubMed] [Google Scholar]
- 9.Hernández-González I.L., Mateo-Estrada V., Castillo-Ramirez S. The promiscuous and highly mobile resistome of Acinetobacter baumannii. Microb. Genom. 2022;8:000762. doi: 10.1099/mgen.0.000762. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Behzadi P., Gajdács M., Pallós P., Ónodi B., Stájer A., Matusovits D., Kárpáti K., Burián K., Battah B., Ferrari M. Relationship between biofilm-formation, phenotypic virulence factors and antibiotic resistance in environmental Pseudomonas aeruginosa. Pathogens. 2022;11:1015. doi: 10.3390/pathogens11091015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Algammal A., Hetta H.F., Mabrok M., Behzadi P. Emerging multidrug-resistant bacterial pathogens “superbugs”: A rising public health threat. Front. Microbiol. 2023;14:1135614. doi: 10.3389/fmicb.2023.1135614. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Karampatakis T., Tsergouli K., Behzadi P. Carbapenem-resistant Klebsiella pneumoniae: Virulence factors, molecular epidemiology and latest updates in treatment options. Antibiotics. 2023;12:234. doi: 10.3390/antibiotics12020234. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Behzadi P., Ambrosi C., Scribano D., Zanetti S., Sarshar M., Gajdács M., Donadu M.G. Current perspectives on Pseudomonas aeruginosa: Epidemiology, virulence and contemporary strategies to combat multidrug-resistant (MDR) pathogens. Front. Microbiol. 2022;13:2870. doi: 10.3389/fmicb.2022.975616. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Li X.-Z., Plésiat P., Nikaido H. The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria. Clin. Microbiol. Rev. 2015;28:337–418. doi: 10.1128/CMR.00117-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Peleg A.Y., de Breij A., Adams M.D., Cerqueira G.M., Mocali S., Galardini M., Nibbering P.H., Earl A.M., Ward D.V., Paterson D.L. The success of Acinetobacter species; genetic, metabolic and virulence attributes. PLoS ONE. 2012;7:e46984. doi: 10.1371/journal.pone.0046984. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Peleg A.Y., Seifert H., Paterson D.L. Acinetobacter baumannii: Emergence of a successful pathogen. Clin. Microbiol. Rev. 2008;21:538–582. doi: 10.1128/CMR.00058-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Hu T., Chitnis N., Monos D., Dinh A. Next-generation sequencing technologies: An overview. Hum. Immunol. 2021;82:801–811. doi: 10.1016/j.humimm.2021.02.012. [DOI] [PubMed] [Google Scholar]
- 18.Bogaty C., Mataseje L., Gray A., Lefebvre B., Lévesque S., Mulvey M., Longtin Y. Investigation of a Carbapenemase-producing Acinetobacter baumannii outbreak using whole genome sequencing versus a standard epidemiologic investigation. Antimicrob. Resist. Infect. Control. 2018;7:1–7. doi: 10.1186/s13756-018-0437-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Hua X., Zhang L., He J., Leptihn S., Yu Y. Population biology and epidemiological studies of Acinetobacter baumannii in the era of whole genome sequencing: Is the Oxford scheme still appropriate? Front. Microbiol. 2020;11:775. doi: 10.3389/fmicb.2020.00775. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Jia H., Chen Y., Wang J., Xie X., Ruan Z. Emerging challenges of whole-genome-sequencing–powered epidemiological surveillance of globally distributed clonal groups of bacterial infections, giving Acinetobacter baumannii ST195 as an example. Int. J. Med. Microbiol. 2019;309:151339. doi: 10.1016/j.ijmm.2019.151339. [DOI] [PubMed] [Google Scholar]
- 21.Rouli L., Merhej V., Fournier P.-E., Raoult D. The bacterial pangenome as a new tool for analysing pathogenic bacteria. New Microbes New Infect. 2015;7:72–85. doi: 10.1016/j.nmni.2015.06.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Carlos Guimaraes L., Benevides de Jesus L., Vinicius Canario Viana M., Silva A., Thiago Juca Ramos R., de Castro Soares S., Azevedo V. Inside the pan-genome-methods and software overview. Curr. Genom. 2015;16:245–252. doi: 10.2174/1389202916666150423002311. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Vernikos G., Medini D., Riley D.R., Tettelin H. Ten years of pan-genome analyses. Curr. Opin. Microbiol. 2015;23:148–154. doi: 10.1016/j.mib.2014.11.016. [DOI] [PubMed] [Google Scholar]
- 24.Caputo A., Fournier P.-E., Raoult D. Genome and pan-genome analysis to classify emerging bacteria. Biol. Direct. 2019;14:1–9. doi: 10.1186/s13062-019-0234-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Medini D., Donati C., Tettelin H., Masignani V., Rappuoli R. The microbial pan-genome. Curr. Opin. Genet. Dev. 2005;15:589–594. doi: 10.1016/j.gde.2005.09.006. [DOI] [PubMed] [Google Scholar]
- 26.Tettelin H., Masignani V., Cieslewicz M.J., Donati C., Medini D., Ward N.L., Angiuoli S.V., Crabtree J., Jones A.L., Durkin A.S. Genome analysis of multiple pathogenic isolates of Streptococcus agalactiae: Implications for the microbial “pan-genome”. Proc. Natl. Acad. Sci. USA. 2005;102:13950–13955. doi: 10.1073/pnas.0506758102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Jaiswal A.K., Tiwari S., Jamal S.B., de Castro Oliveira L., Alves L.G., Azevedo V., Ghosh P., Oliveira C.J.F., Soares S.C. The pan-genome of Treponema pallidum reveals differences in genome plasticity between subspecies related to venereal and non-venereal syphilis. BMC Genom. 2020;21:33. doi: 10.1186/s12864-019-6430-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Tantoso E., Eisenhaber B., Sinha S., Jensen L.J., Eisenhaber F. About the dark corners in the gene function space of Escherichia coli remaining without illumination by scientific literature. Biol. Direct. 2023;18:7. doi: 10.1186/s13062-023-00362-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Tantoso E., Eisenhaber B., Kirsch M., Shitov V., Zhao Z., Eisenhaber F. To kill or to be killed: Pangenome analysis of Escherichia coli strains reveals a tailocin specific for pandemic ST131. BMC Biol. 2022;20:146. doi: 10.1186/s12915-022-01347-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Urhan A., Abeel T. A comparative study of pan-genome methods for microbial organisms: Acinetobacter baumannii pan-genome reveals structural variation in antimicrobial resistance-carrying plasmids. Microb. Genom. 2021;7:000690. doi: 10.1099/mgen.0.000690. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Mira A., Martín-Cuadrado A.B., D’Auria G., Rodríguez-Valera F. The bacterial pan-genome: A new paradigm in microbiology. Int. Microbiol. 2010;13:45–57. doi: 10.2436/20.1501.01.110. [DOI] [PubMed] [Google Scholar]
- 32.Sugiyama H. Tumor immunology. Editorial overview. Curr. Opin. Immunol. 2008;20:208–210. doi: 10.1016/j.coi.2008.05.001. [DOI] [PubMed] [Google Scholar]
- 33.Jordan I.K., Makarova K.S., Spouge J.L., Wolf Y.I., Koonin E.V. Lineage-specific gene expansions in bacterial and archaeal genomes. Genome Res. 2001;11:555–565. doi: 10.1101/gr.166001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Soares S.C., Abreu V.A., Ramos R.T., Cerdeira L., Silva A., Baumbach J., Trost E., Tauch A., Hirata R., Jr., Mattos-Guaraldi A.L. PIPS: Pathogenicity island prediction software. PLoS ONE. 2012;7:e30848. doi: 10.1371/journal.pone.0030848. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Sonnenberg C.B., Kahlke T., Haugen P. Vibrionaceae core, shell and cloud genes are non-randomly distributed on Chr 1: An hypothesis that links the genomic location of genes with their intracellular placement. BMC Genom. 2020;21:695. doi: 10.1186/s12864-020-07117-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Tettelin H., Riley D., Cattuto C., Medini D. Comparative genomics: The bacterial pan-genome. Curr. Opin. Microbiol. 2008;11:472–477. doi: 10.1016/j.mib.2008.09.006. [DOI] [PubMed] [Google Scholar]
- 37.Lean S.S., Yeo C.C. Small, enigmatic plasmids of the nosocomial pathogen, Acinetobacter baumannii: Good, bad, who knows? Front. Microbiol. 2017;8:1547. doi: 10.3389/fmicb.2017.01547. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Noel H.R., Petrey J.R., Palmer L.D. Mobile genetic elements in Acinetobacter antibiotic-resistance acquisition and dissemination. Ann. N. Y. Acad. Sci. 2022;1518:166–182. doi: 10.1111/nyas.14918. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Behzadi P., Ranjbar R., Alavian S.M. Nucleic acid-based approaches for detection of viral hepatitis. Jundishapur J. Microbiol. 2015;8:e17449. doi: 10.5812/jjm.17449. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Sahl J.W., Gillece J.D., Schupp J.M., Waddell V.G., Driebe E.M., Engelthaler D.M., Keim P. Evolution of a pathogen: A comparative genomics analysis identifies a genetic pathway to pathogenesis in Acinetobacter. PLoS ONE. 2013;8:e54287. doi: 10.1371/journal.pone.0054287. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Gaiarsa S., Bitar I., Comandatore F., Corbella M., Piazza A., Scaltriti E., Villa L., Postiglione U., Marone P., Nucleo E. Can insertion sequences proliferation influence genomic plasticity? Comparative analysis of Acinetobacter baumannii sequence type 78, a persistent clone in Italian hospitals. Front. Microbiol. 2019;10:2080. doi: 10.3389/fmicb.2019.02080. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Imperi F., Antunes L.C., Blom J., Villa L., Iacono M., Visca P., Carattoli A. The genomics of Acinetobacter baumannii: Insights into genome plasticity, antimicrobial resistance and pathogenicity. IUBMB Life. 2011;63:1068–1074. doi: 10.1002/iub.531. [DOI] [PubMed] [Google Scholar]
- 43.Costa A.R., Monteiro R., Azeredo J. Genomic analysis of Acinetobacter baumannii prophages reveals remarkable diversity and suggests profound impact on bacterial virulence and fitness. Sci. Rep. 2018;8:15346. doi: 10.1038/s41598-018-33800-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Ramirez M.S., Bonomo R.A., Tolmasky M.E. Carbapenemases: Transforming Acinetobacter baumannii into a yet more dangerous menace. Biomolecules. 2020;10:720. doi: 10.3390/biom10050720. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Hamidian M., Hawkey J., Wick R., Holt K.E., Hall R.M. Evolution of a clade of Acinetobacter baumannii global clone 1, lineage 1 via acquisition of carbapenem-and aminoglycoside-resistance genes and dispersion of ISAba1. Microb. Genom. 2019;5:e000242. doi: 10.1099/mgen.0.000242. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Hamidian M., Nigro S.J. Emergence, molecular mechanisms and global spread of carbapenem-resistant Acinetobacter baumannii. Microb. Genom. 2019;5:e000306. doi: 10.1099/mgen.0.000306. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Hickman A.B., Dyda F. Mechanisms of DNA transposition. Microbiol. Spectr. 2015;3:MDNA3-2014. doi: 10.1128/microbiolspec.MDNA3-0034-2014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Babakhani S., Oloomi M. Transposons: The agents of antibiotic resistance in bacteria. J. Basic Microbiol. 2018;58:905–917. doi: 10.1002/jobm.201800204. [DOI] [PubMed] [Google Scholar]
- 49.Partridge S.R., Kwong S.M., Firth N., Jensen S.O. Mobile genetic elements associated with antimicrobial resistance. Clin. Microbiol. Rev. 2018;31.:e00088-17. doi: 10.1128/CMR.00088-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Cambray G., Guerout A.-M., Mazel D. Integrons. Annu. Rev. Genet. 2010;44:141–166. doi: 10.1146/annurev-genet-102209-163504. [DOI] [PubMed] [Google Scholar]
- 51.Partridge S.R., Tsafnat G., Coiera E., Iredell J.R. Gene cassettes and cassette arrays in mobile resistance integrons. FEMS Microbiol. Rev. 2009;33:757–784. doi: 10.1111/j.1574-6976.2009.00175.x. [DOI] [PubMed] [Google Scholar]
- 52.Delihas N. Small mobile sequences in bacteria display diverse structure/function motifs. Mol. Microbiol. 2008;67:475–481. doi: 10.1111/j.1365-2958.2007.06068.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Domingues S., Nielsen K.M., da Silva G.J. The bla IMP-5-carrying integron in a clinical Acinetobacter baumannii strain is flanked by miniature inverted-repeat transposable elements (MITEs) J. Antimicrob. Chemother. 2011;66:2667–2668. doi: 10.1093/jac/dkr327. [DOI] [PubMed] [Google Scholar]
- 54.Zong Z. The complex genetic context of bla PER-1 flanked by miniature inverted-repeat transposable elements in Acinetobacter johnsonii. PLoS ONE. 2014;9:e90046. doi: 10.1371/journal.pone.0090046. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Ranjbar R., Behzadi P., Najafi A., Roudi R. DNA microarray for rapid detection and identification of food and water borne bacteria: From dry to wet lab. Open Microbiol. J. 2017;11:330. doi: 10.2174/1874285801711010330. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Behzadi P., Behzadi E., Alavian S.M. DNA microarray technology in HBV genotyping. Minerva Med. 2017;108:473–476. doi: 10.23736/S0026-4806.17.05059-5. [DOI] [PubMed] [Google Scholar]
- 57.Ranjbar R., Behzadi P., Mammina C. Respiratory tularemia: Francisella tularensis and microarray probe designing. Open Microbiol. J. 2016;10:176. doi: 10.2174/1874285801610010176. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Soares S.C., Geyik H., Ramos R.T., de Sá P.H., Barbosa E.G., Baumbach J., Figueiredo H.C., Miyoshi A., Tauch A., Silva A. GIPSy: Genomic island prediction software. J. Biotechnol. 2016;232:2–11. doi: 10.1016/j.jbiotec.2015.09.008. [DOI] [PubMed] [Google Scholar]
- 59.Bertelli C., Tilley K.E., Brinkman F.S. Microbial genomic island discovery, visualization and analysis. Brief. Bioinform. 2019;20:1685–1698. doi: 10.1093/bib/bby042. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Evans B.A., Amyes S.G. OXA β-lactamases. Clin. Microbiol. Rev. 2014;27:241–263. doi: 10.1128/CMR.00117-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.de Almeida O.G.G., Furlan J.P.R., Stehling E.G., De Martinis E.C.P. Comparative phylo-pangenomics reveals generalist lifestyles in representative Acinetobacter species and proposes candidate gene markers for species identification. Gene. 2021;791:145707. doi: 10.1016/j.gene.2021.145707. [DOI] [PubMed] [Google Scholar]
- 62.Lucidi M., Imperi F., Artuso I., Capecchi G., Spagnoli C., Visaggio D., Rampioni G., Leoni L., Visca P. Phage-mediated colistin resistance in Acinetobacter baumannii. Drug Resist. Updates. 2024;73:101061. doi: 10.1016/j.drup.2024.101061. [DOI] [PubMed] [Google Scholar]
- 63.Kyriakidis I., Vasileiou E., Pana Z.D., Tragiannidis A. Acinetobacter baumannii antibiotic resistance mechanisms. Pathogens. 2021;10:373. doi: 10.3390/pathogens10030373. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Ayoub Moubareck C., Hammoudi Halat D. Insights into Acinetobacter baumannii: A review of microbiological, virulence, and resistance traits in a threatening nosocomial pathogen. Antibiotics. 2020;9:119. doi: 10.3390/antibiotics9030119. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Shi J., Cheng J., Liu S., Zhu Y., Zhu M. Acinetobacter baumannii: An evolving and cunning opponent. Front. Microbiol. 2024;15:1332108. doi: 10.3389/fmicb.2024.1332108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Wachino J.-i., Jin W., Kimura K., Arakawa Y. Intercellular transfer of chromosomal antimicrobial resistance genes between Acinetobacter baumannii strains mediated by prophages. Antimicrob. Agents Chemother. 2019;63:10–1128. doi: 10.1128/AAC.00334-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.López-Leal G., Santamaria R.I., Cevallos M.Á., Gonzalez V., Castillo-Ramírez S. Prophages encode antibiotic resistance genes in Acinetobacter baumannii. Microb. Drug Resist. 2020;26:1275–1277. doi: 10.1089/mdr.2019.0362. [DOI] [PubMed] [Google Scholar]
- 68.Shadan A., Pathak A., Ma Y., Pathania R., Singh R.P. Deciphering the virulence factors, regulation, and immune response to Acinetobacter baumannii infection. Front. Cell. Infect. Microbiol. 2023;13:156. doi: 10.3389/fcimb.2023.1053968. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Maure A., Robino E., Van der Henst C. The intracellular life of Acinetobacter baumannii. Trends Microbiol. 2023;31:1238–1250. doi: 10.1016/j.tim.2023.06.007. [DOI] [PubMed] [Google Scholar]
- 70.Brovedan M.A., Cameranesi M.M., Limansky A.S., Morán-Barrio J., Marchiaro P., Repizo G.D. What do we know about plasmids carried by members of the Acinetobacter genus? World J. Microbiol. Biotechnol. 2020;36:109. doi: 10.1007/s11274-020-02890-7. [DOI] [PubMed] [Google Scholar]
- 71.Geisinger E., Isberg R.R. Antibiotic modulation of capsular exopolysaccharide and virulence in Acinetobacter baumannii. PLoS Pathog. 2015;11:e1004691. doi: 10.1371/journal.ppat.1004691. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Talyansky Y., Nielsen T.B., Yan J., Carlino-Macdonald U., Di Venanzio G., Chakravorty S., Ulhaq A., Feldman M.F., Russo T.A., Vinogradov E. Capsule carbohydrate structure determines virulence in Acinetobacter baumannii. PLoS Pathog. 2021;17:e1009291. doi: 10.1371/journal.ppat.1009291. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Russo T.A., Luke N.R., Beanan J.M., Olson R., Sauberan S.L., MacDonald U., Schultz L.W., Umland T.C., Campagnari A.A. The K1 capsular polysaccharide of Acinetobacter baumannii strain 307-0294 is a major virulence factor. Infect. Immun. 2010;78:3993–4000. doi: 10.1128/IAI.00366-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Shashkov A.S., Liu B., Kenyon J.J., Popova A.V., Shneider M.M., Sof’ya N.S., Arbatsky N.P., Miroshnikov K.A., Wang L., Knirel Y.A. Structures of the K35 and K15 capsular polysaccharides of Acinetobacter baumannii LUH5535 and LUH5554 containing amino and diamino uronic acids. Carbohydr. Res. 2017;448:28–34. doi: 10.1016/j.carres.2017.05.017. [DOI] [PubMed] [Google Scholar]
- 75.Shashkov A.S., Kenyon J.J., Arbatsky N.P., Shneider M.M., Popova A.V., Knirel Y.A., Hall R.M. Genetics of biosynthesis and structure of the K53 capsular polysaccharide of Acinetobacter baumannii D23 made up of a disaccharide K unit. Microbiology. 2018;164:1289–1292. doi: 10.1099/mic.0.000710. [DOI] [PubMed] [Google Scholar]
- 76.Kröger C., Kary S.C., Schauer K., Cameron A.D. Genetic regulation of virulence and antibiotic resistance in Acinetobacter baumannii. Genes. 2016;8:12. doi: 10.3390/genes8010012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Upmanyu K., Haq Q.M.R., Singh R. Factors mediating Acinetobacter baumannii biofilm formation: Opportunities for developing therapeutics. Curr. Res. Microb. Sci. 2022;3:100131. doi: 10.1016/j.crmicr.2022.100131. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.Darby E.M., Bavro V.N., Dunn S., McNally A., Blair J.M. RND pumps across the genus Acinetobacter: AdeIJK is the universal efflux pump. Microb. Genom. 2023;9:mgen000964. doi: 10.1099/mgen.0.000964. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79.Vila J., Martí S., Sanchez-Céspedes J. Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii. J. Antimicrob. Chemother. 2007;59:1210–1215. doi: 10.1093/jac/dkl509. [DOI] [PubMed] [Google Scholar]
- 80.Kornelsen V., Kumar A. Update on multidrug resistance efflux pumps in Acinetobacter spp. Antimicrob. Agents Chemother. 2021;65:e0051421. doi: 10.1128/AAC.00514-21. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81.Du D., Wang-Kan X., Neuberger A., Van Veen H.W., Pos K.M., Piddock L.J., Luisi B.F. Multidrug efflux pumps: Structure, function and regulation. Nat. Rev. Microbiol. 2018;16:523–539. doi: 10.1038/s41579-018-0048-6. [DOI] [PubMed] [Google Scholar]
- 82.Coyne S., Courvalin P., Périchon B. Efflux-mediated antibiotic resistance in Acinetobacter spp. Antimicrob. Agents Chemother. 2011;55:947–953. doi: 10.1128/AAC.01388-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83.Magnet S., Courvalin P., Lambert T. Resistance-nodulation-cell division-type efflux pump involved in aminoglycoside resistance in Acinetobacter baumannii strain BM4454. Antimicrob. Agents Chemother. 2001;45:3375–3380. doi: 10.1128/AAC.45.12.3375-3380.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84.Pérez-Varela M., Corral J., Aranda J., Barbé J. Roles of efflux pumps from different superfamilies in the surface-associated motility and virulence of Acinetobacter baumannii ATCC 17978. Antimicrob. Agents Chemother. 2019;63:e02190-18. doi: 10.1128/AAC.02190-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85.He X., Lu F., Yuan F., Jiang D., Zhao P., Zhu J., Cheng H., Cao J., Lu G. Biofilm formation caused by clinical Acinetobacter baumannii isolates is associated with overexpression of the AdeFGH efflux pump. Antimicrob. Agents Chemother. 2015;59:4817–4825. doi: 10.1128/AAC.00877-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 86.Li P., Zhang S., Wang J., Al-Shamiri M.M., Han B., Chen Y., Han S., Han L. Uncovering the Secretion Systems of Acinetobacter baumannii: Structures and Functions in Pathogenicity and Antibiotic Resistance. Antibiotics. 2023;12:195. doi: 10.3390/antibiotics12020195. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 87.Behzadi P., Sameer A.S., Nissar S., Banday M.Z., Gajdács M., García-Perdomo H.A., Akhtar K., Pinheiro M., Magnusson P., Sarshar M. The Interleukin-1 (IL-1) superfamily cytokines and their single nucleotide polymorphisms (SNPs) J. Immunol. Res. 2022;2022:2054431. doi: 10.1155/2022/2054431. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 88.Nikaido H. Molecular basis of bacterial outer membrane permeability revisited. Microbiol. Mol. Biol. Rev. 2003;67:593–656. doi: 10.1128/MMBR.67.4.593-656.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 89.Carpenter T.S., Parkin J., Khalid S. The free energy of small solute permeation through the Escherichia coli outer membrane has a distinctly asymmetric profile. J. Phys. Chem. Lett. 2016;7:3446–3451. doi: 10.1021/acs.jpclett.6b01399. [DOI] [PubMed] [Google Scholar]
- 90.Needham B.D., Trent M.S. Fortifying the barrier: The impact of lipid A remodelling on bacterial pathogenesis. Nat. Rev. Microbiol. 2013;11:467–481. doi: 10.1038/nrmicro3047. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 91.Bertani B., Ruiz N. Function and biogenesis of lipopolysaccharides. EcoSal Plus. 2018;8:10-1128. doi: 10.1128/ecosalplus.esp-0001-2018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 92.Mukherjee S., Patra R., Behzadi P., Masotti A., Paolini A., Sarshar M. Toll-like receptor-guided therapeutic intervention of human cancers: Molecular and immunological perspectives. Front. Immunol. 2023;14:1244345. doi: 10.3389/fimmu.2023.1244345. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 93.Behzadi P., Kim C.-H., Pawlak E.A., Algammal A. The innate and adaptive immune system in human urinary system. Front. Immunol. 2023;14:1294869. doi: 10.3389/fimmu.2023.1294869. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 94.Kikuchi-Ueda T., Ubagai T., Kamoshida G., Nakano R., Nakano A., Ono Y. Acinetobacter baumannii los regulate the expression of inflammatory cytokine genes and proteins in human mast cells. Pathogens. 2021;10:290. doi: 10.3390/pathogens10030290. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 95.Moffatt J.H., Harper M., Harrison P., Hale J.D., Vinogradov E., Seemann T., Henry R., Crane B., St. Michael F., Cox A.D. Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production. Antimicrob. Agents Chemother. 2010;54:4971–4977. doi: 10.1128/AAC.00834-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 96.Kenyon J.J., Nigro S.J., Hall R.M. Variation in the OC locus of Acinetobacter baumannii genomes predicts extensive structural diversity in the lipooligosaccharide. PLoS ONE. 2014;9:e107833. doi: 10.1371/journal.pone.0107833. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 97.Zhang G., Meredith T.C., Kahne D. On the essentiality of lipopolysaccharide to Gram-negative bacteria. Curr. Opin. Microbiol. 2013;16:779–785. doi: 10.1016/j.mib.2013.09.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 98.McQueary C.N., Kirkup B.C., Si Y., Barlow M., Actis L.A., Craft D.W., Zurawski D.V. Extracellular stress and lipopolysaccharide modulate Acinetobacter baumannii surface-associated motility. J. Microbiol. 2012;50:434–443. doi: 10.1007/s12275-012-1555-1. [DOI] [PubMed] [Google Scholar]
- 99.Soon R.L., Nation R.L., Harper M., Adler B., Boyce J.D., Tan C.-H., Li J., Larson I. Effect of colistin exposure and growth phase on the surface properties of live Acinetobacter baumannii cells examined by atomic force microscopy. Int. J. Antimicrob. Agents. 2011;38:493–501. doi: 10.1016/j.ijantimicag.2011.07.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 100.Lin L., Tan B., Pantapalangkoor P., Ho T., Baquir B., Tomaras A., Montgomery J.I., Reilly U., Barbacci E.G., Hujer K. Inhibition of LpxC protects mice from resistant Acinetobacter baumannii by modulating inflammation and enhancing phagocytosis. MBio. 2012;3:e00312-12. doi: 10.1128/mBio.00312-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 101.Luke N.R., Sauberan S.L., Russo T.A., Beanan J.M., Olson R., Loehfelm T.W., Cox A.D., St. Michael F., Vinogradov E.V., Campagnari A.A. Identification and characterization of a glycosyltransferase involved in Acinetobacter baumannii lipopolysaccharide core biosynthesis. Infect. Immun. 2010;78:2017–2023. doi: 10.1128/IAI.00016-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 102.Erridge C., Moncayo-Nieto O.L., Morgan R., Young M., Poxton I.R. Acinetobacter baumannii lipopolysaccharides are potent stimulators of human monocyte activation via Toll-like receptor 4 signalling. J. Med. Microbiol. 2007;56:165–171. doi: 10.1099/jmm.0.46823-0. [DOI] [PubMed] [Google Scholar]
- 103.Beceiro A., Llobet E., Aranda J., Bengoechea J.A., Doumith M., Hornsey M., Dhanji H., Chart H., Bou G., Livermore D.M. Phosphoethanolamine modification of lipid A in colistin-resistant variants of Acinetobacter baumannii mediated by the pmrAB two-component regulatory system. Antimicrob. Agents Chemother. 2011;55:3370–3379. doi: 10.1128/AAC.00079-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 104.Pelletier M.R., Casella L.G., Jones J.W., Adams M.D., Zurawski D.V., Hazlett K.R., Doi Y., Ernst R.K. Unique structural modifications are present in the lipopolysaccharide from colistin-resistant strains of Acinetobacter baumannii. Antimicrob. Agents Chemother. 2013;57:4831–4840. doi: 10.1128/AAC.00865-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 105.Hood M.I., Becker K.W., Roux C.M., Dunman P.M., Skaar E.P. Genetic determinants of intrinsic colistin tolerance in Acinetobacter baumannii. Infect. Immun. 2013;81:542–551. doi: 10.1128/IAI.00704-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 106.Heinrichs D.E., Yethon J.A., Whitfield C. Molecular basis for structural diversity in the core regions of the lipopolysaccharides of Escherichia coli and Salmonella enterica. Mol. Microbiol. 1998;30:221–232. doi: 10.1046/j.1365-2958.1998.01063.x. [DOI] [PubMed] [Google Scholar]
- 107.Kenyon J.J., Hall R.M. Variation in the complex carbohydrate biosynthesis loci of Acinetobacter baumannii genomes. PLoS ONE. 2013;8:e62160. doi: 10.1371/journal.pone.0062160. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 108.Smani Y., McConnell M.J., Pachón J. Role of fibronectin in the adhesion of Acinetobacter baumannii to host cells. PLoS ONE. 2012;7:e33073. doi: 10.1371/journal.pone.0033073. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 109.Schweppe D.K., Harding C., Chavez J.D., Wu X., Ramage E., Singh P.K., Manoil C., Bruce J.E. Host-microbe protein interactions during bacterial infection. Chem. Biol. 2015;22:1521–1530. doi: 10.1016/j.chembiol.2015.09.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 110.Choi C.H., Lee E.Y., Lee Y.C., Park T.I., Kim H.J., Hyun S.H., Kim S.A., Lee S.K., Lee J.C. Outer membrane protein 38 of Acinetobacter baumannii localizes to the mitochondria and induces apoptosis of epithelial cells. Cell. Microbiol. 2005;7:1127–1138. doi: 10.1111/j.1462-5822.2005.00538.x. [DOI] [PubMed] [Google Scholar]
- 111.Smani Y., Fàbrega A., Roca I., Sánchez-Encinales V., Vila J., Pachón J. Role of OmpA in the multidrug resistance phenotype of Acinetobacter baumannii. Antimicrob. Agents Chemother. 2014;58:1806–1808. doi: 10.1128/AAC.02101-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 112.Behzadi P., Behzadi E. Detection of apoptosis feature in ultraviolet light-exposed Trichophyton rubrum. Turkiye Klinikleri J. Med. Sci. 2006;26:607–610. [Google Scholar]
- 113.Gaddy J.A., Tomaras A.P., Actis L.A. The Acinetobacter baumannii 19606 OmpA protein plays a role in biofilm formation on abiotic surfaces and in the interaction of this pathogen with eukaryotic cells. Infect. Immun. 2009;77:3150–3160. doi: 10.1128/IAI.00096-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 114.Moon D.C., Choi C.H., Lee J.H., Choi C.-W., Kim H.-Y., Park J.S., Kim S.I., Lee J.C. Acinetobacter baumannii outer membrane protein A modulates the biogenesis of outer membrane vesicles. J. Microbiol. 2012;50:155–160. doi: 10.1007/s12275-012-1589-4. [DOI] [PubMed] [Google Scholar]
- 115.Iyer R., Moussa S.H., Durand-Reville T.F., Tommasi R., Miller A. Acinetobacter baumannii OmpA is a selective antibiotic permeant porin. ACS Infect. Dis. 2017;4:373–381. doi: 10.1021/acsinfecdis.7b00168. [DOI] [PubMed] [Google Scholar]
- 116.Ansari H., Doosti A., Kargar M., Bijanzadeh M., Jaafarinia M. Cloning of ompA gene from Acinetobacter baumannii into the eukaryotic expression vector pBudCE4. 1 as DNA vaccine. Indian J. Microbiol. 2018;58:174–181. doi: 10.1007/s12088-017-0705-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 117.Zhang W., Zhou H., Jiang Y., He J., Yao Y., Wang J., Liu X., Leptihn S., Hua X., Yu Y. Acinetobacter baumannii outer membrane protein A induces pulmonary epithelial barrier dysfunction and bacterial translocation through the TLR2/IQGAP1 axis. Front. Immunol. 2022;13:927955. doi: 10.3389/fimmu.2022.927955. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 118.Jin J.S., Kwon S.-O., Moon D.C., Gurung M., Lee J.H., Kim S.I., Lee J.C. Acinetobacter baumannii secretes cytotoxic outer membrane protein A via outer membrane vesicles. PLoS ONE. 2011;6:e17027. doi: 10.1371/journal.pone.0017027. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 119.Catel-Ferreira M., Marti S., Guillon L., Jara L., Coadou G., Molle V., Bouffartigues E., Bou G., Shalk I., Jouenne T. The outer membrane porin OmpW of Acinetobacter baumannii is involved in iron uptake and colistin binding. FEBS Lett. 2016;590:224–231. doi: 10.1002/1873-3468.12050. [DOI] [PubMed] [Google Scholar]
- 120.Gil-Marqués M.L., Pachón J., Smani Y. iTRAQ-based quantitative proteomic analysis of Acinetobacter baumannii under hypoxia and normoxia reveals the role of OmpW as a virulence factor. Microbiol. Spectr. 2022;10:e0232821. doi: 10.1128/spectrum.02328-21. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 121.Nwugo C.C., Gaddy J.A., Zimbler D.L., Actis L.A. Deciphering the iron response in Acinetobacter baumannii: A proteomics approach. J. Proteom. 2011;74:44–58. doi: 10.1016/j.jprot.2010.07.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 122.Geisinger E., Mortman N.J., Vargas-Cuebas G., Tai A.K., Isberg R.R. A global regulatory system links virulence and antibiotic resistance to envelope homeostasis in Acinetobacter baumannii. PLoS Pathog. 2018;14:e1007030. doi: 10.1371/journal.ppat.1007030. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 123.Mussi M.A., Relling V.M., Limansky A.S., Viale A.M. CarO, an Acinetobacter baumannii outer membrane protein involved in carbapenem resistance, is essential for L-ornithine uptake. FEBS Lett. 2007;581:5573–5578. doi: 10.1016/j.febslet.2007.10.063. [DOI] [PubMed] [Google Scholar]
- 124.Labrador-Herrera G., Pérez-Pulido A.J., Álvarez-Marín R., Casimiro-Soriguer C.S., Cebrero-Cangueiro T., Morán-Barrio J., Pachón J., Viale A.M., Pachón-Ibáñez M.E. Virulence role of the outer membrane protein CarO in carbapenem-resistant Acinetobacter baumannii. Virulence. 2020;11:1727–1737. doi: 10.1080/21505594.2020.1855912. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 125.Uppalapati S.R., Sett A., Pathania R. The outer membrane proteins OmpA, CarO, and OprD of Acinetobacter baumannii confer a two-pronged defense in facilitating its success as a potent human pathogen. Front. Microbiol. 2020;11:589234. doi: 10.3389/fmicb.2020.589234. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 126.Zahn M., Bhamidimarri S.P., Baslé A., Winterhalter M., Van den Berg B. Structural insights into outer membrane permeability of Acinetobacter baumannii. Structure. 2016;24:221–231. doi: 10.1016/j.str.2015.12.009. [DOI] [PubMed] [Google Scholar]
- 127.Dupont M., Pagès J.-M., Lafitte D., Siroy A., Bollet C. Identification of an OprD Homologue in Acinetobacter baumannii. J. Proteome Res. 2005;4:2386–2390. doi: 10.1021/pr050143q. [DOI] [PubMed] [Google Scholar]
- 128.Sakyo S., Tomita H., Tanimoto K., Fujimoto S., Ike Y. Potency of carbapenems for the prevention of carbapenem-resistant mutants of Pseudomonas aeruginosa. J. Antibiot. 2006;59:220–228. doi: 10.1038/ja.2006.31. [DOI] [PubMed] [Google Scholar]
- 129.Catel-Ferreira M., Nehmé R., Molle V., Aranda J., Bouffartigues E., Chevalier S., Bou G., Jouenne T., Dé E. Deciphering the function of the outer membrane protein OprD homologue of Acinetobacter baumannii. Antimicrob. Agents Chemother. 2012;56:3826–3832. doi: 10.1128/AAC.06022-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 130.Hua M., Liu J., Du P., Liu X., Li M., Wang H., Chen C., Xu X., Jiang Y., Wang Y. The novel outer membrane protein from OprD/Occ family is associated with hypervirulence of carbapenem resistant Acinetobacter baumannii ST2/KL22. Virulence. 2021;12:1–11. doi: 10.1080/21505594.2020.1856560. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 131.Rumbo C., Tomás M., Fernandez Moreira E., Soares N.C., Carvajal M., Santillana E., Beceiro A., Romero A., Bou G. The Acinetobacter baumannii Omp33-36 porin is a virulence factor that induces apoptosis and modulates autophagy in human cells. Infect. Immun. 2014;82:4666–4680. doi: 10.1128/IAI.02034-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 132.Hospenthal M.K., Costa T.R., Waksman G. A comprehensive guide to pilus biogenesis in Gram-negative bacteria. Nat. Rev. Microbiol. 2017;15:365–379. doi: 10.1038/nrmicro.2017.40. [DOI] [PubMed] [Google Scholar]
- 133.Ramezanalizadeh F., Owlia P., Rasooli I. Type I pili, CsuA/B and FimA induce a protective immune response against Acinetobacter baumannii. Vaccine. 2020;38:5436–5446. doi: 10.1016/j.vaccine.2020.06.052. [DOI] [PubMed] [Google Scholar]
- 134.Eijkelkamp B.A., Stroeher U.H., Hassan K.A., Paulsen I.T., Brown M.H. Comparative analysis of surface-exposed virulence factors of Acinetobacter baumannii. BMC Genom. 2014;15:1020. doi: 10.1186/1471-2164-15-1020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 135.de Breij A., Gaddy J., van der Meer J., Koning R., Koster A., van den Broek P., Actis L., Nibbering P., Dijkshoorn L. CsuA/BABCDE-dependent pili are not involved in the adherence of Acinetobacter baumannii ATCC19606T to human airway epithelial cells and their inflammatory response. Res. Microbiol. 2009;160:213–218. doi: 10.1016/j.resmic.2009.01.002. [DOI] [PubMed] [Google Scholar]
- 136.Aranda J., López M., Leiva E., Magán A., Adler B., Bou G., Barbé J. Role of Acinetobacter baumannii UmuD homologs in antibiotic resistance acquired through DNA damage-induced mutagenesis. Antimicrob. Agents Chemother. 2014;58:1771–1773. doi: 10.1128/AAC.02346-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 137.Chlebek J.L., Hughes H.Q., Ratkiewicz A.S., Rayyan R., Wang J.C.-Y., Herrin B.E., Dalia T.N., Biais N., Dalia A.B. PilT and PilU are homohexameric ATPases that coordinate to retract type IVa pili. PLoS Genet. 2019;15:e1008448. doi: 10.1371/journal.pgen.1008448. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 138.Cerqueira G.M., Kostoulias X., Khoo C., Aibinu I., Qu Y., Traven A., Peleg A.Y. A global virulence regulator in Acinetobacter baumannii and its control of the phenylacetic acid catabolic pathway. J. Infect. Dis. 2014;210:46–55. doi: 10.1093/infdis/jiu024. [DOI] [PubMed] [Google Scholar]
- 139.Harding C.M., Tracy E.N., Carruthers M.D., Rather P.N., Actis L.A., Munson R.S., Jr. Acinetobacter baumannii strain M2 produces type IV pili which play a role in natural transformation and twitching motility but not surface-associated motility. MBio. 2013;4.:e00360-13. doi: 10.1128/mBio.00360-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 140.Ronish L.A., Lillehoj E., Fields J.K., Sundberg E.J., Piepenbrink K.H. The structure of PilA from Acinetobacter baumannii AB5075 suggests a mechanism for functional specialization in Acinetobacter type IV pili. J. Biol. Chem. 2019;294:218–230. doi: 10.1074/jbc.RA118.005814. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 141.Benomar S., Di Venanzio G., Feldman M.F. Plasmid-encoded H-NS controls extracellular matrix composition in a modern Acinetobacter baumannii urinary isolate. J. Bacteriol. 2021;203:e0027721. doi: 10.1128/JB.00277-21. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 142.Cook-Libin S., Sykes E.M., Kornelsen V., Kumar A. Iron acquisition mechanisms and their role in the virulence of Acinetobacter baumannii. Infect. Immun. 2022;90:e00223-22. doi: 10.1128/iai.00223-22. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 143.Nakashige T.G., Zhang B., Krebs C., Nolan E.M. Human calprotectin is an iron-sequestering host-defense protein. Nat. Chem. Biol. 2015;11:765–771. doi: 10.1038/nchembio.1891. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 144.Fiester S.E., Arivett B.A., Schmidt R.E., Beckett A.C., Ticak T., Carrier M.V., Ghosh R., Ohneck E.J., Metz M.L., Sellin Jeffries M.K. Iron-regulated phospholipase C activity contributes to the cytolytic activity and virulence of Acinetobacter baumannii. PLoS ONE. 2016;11:e0167068. doi: 10.1371/journal.pone.0167068. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 145.Giardina B.J., Shahzad S., Huang W., Wilks A. Heme uptake and utilization by hypervirulent Acinetobacter baumannii LAC-4 is dependent on a canonical heme oxygenase (abHemO) Arch. Biochem. Biophys. 2019;672:108066. doi: 10.1016/j.abb.2019.108066. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 146.Bateman T.J., Shah M., Ho T.P., Shin H.E., Pan C., Harris G., Fegan J.E., Islam E.A., Ahn S.K., Hooda Y. A Slam-dependent hemophore contributes to heme acquisition in the bacterial pathogen Acinetobacter baumannii. Nat. Commun. 2021;12:6270. doi: 10.1038/s41467-021-26545-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 147.Sheldon J.R., Skaar E.P. Acinetobacter baumannii can use multiple siderophores for iron acquisition, but only acinetobactin is required for virulence. PLoS Pathog. 2020;16:e1008995. doi: 10.1371/journal.ppat.1008995. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 148.Hasan T., Choi C.H., Oh M.H. Genes Involved in the Biosynthesis and Transport of Acinetobactin in Acinetobacter baumannii. Genom. Inform. 2015;13:2. doi: 10.5808/GI.2015.13.1.2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 149.Hood M.I., Mortensen B.L., Moore J.L., Zhang Y., Kehl-Fie T.E., Sugitani N., Chazin W.J., Caprioli R.M., Skaar E.P. Identification of an Acinetobacter baumannii zinc acquisition system that facilitates resistance to calprotectin-mediated zinc sequestration. PLoS Pathog. 2012;8:e1003068. doi: 10.1371/journal.ppat.1003068. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 150.Mortensen B.L., Rathi S., Chazin W.J., Skaar E.P. Acinetobacter baumannii response to host-mediated zinc limitation requires the transcriptional regulator Zur. J. Bacteriol. 2014;196:2616–2626. doi: 10.1128/JB.01650-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 151.Häse C., Finkelstein R.A. Bacterial extracellular zinc-containing metalloproteases. Microbiol. Rev. 1993;57:823–837. doi: 10.1128/mr.57.4.823-837.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 152.Heydari S.F., Ghollasi M., Ghiasi M., Behzadi P. Evaluation of the Effect of Curcumin on the Expression of Matrix Metalloproteinase Genes in RAW264. 7 Cell Line Treated with Diethylhexyl Phthalate. J. Appl. Biotechnol. Rep. 2023;10:926–933. [Google Scholar]
- 153.Green E.R., Juttukonda L.J., Skaar E.P. The manganese-responsive transcriptional regulator MumR protects Acinetobacter baumannii from oxidative stress. Infect. Immun. 2020;88:e00762-19. doi: 10.1128/IAI.00762-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 154.Juttukonda L., Chazin W., Skaar E. Acinetobacter baumannii coordinates urea metabolism with metal import to resist host-mediated metal limitation. mBio. 2016;7:e01475-16. doi: 10.1128/mBio.01475-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 155.De Silva P.M., Kumar A. Signal transduction proteins in Acinetobacter baumannii: Role in antibiotic resistance, virulence, and potential as drug targets. Front. Microbiol. 2019;10:49. doi: 10.3389/fmicb.2019.00049. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 156.Zschiedrich C.P., Keidel V., Szurmant H. Molecular mechanisms of two-component signal transduction. J. Mol. Biol. 2016;428:3752–3775. doi: 10.1016/j.jmb.2016.08.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 157.Singh J.K., Adams F.G., Brown M.H. Diversity and function of capsular polysaccharide in Acinetobacter baumannii. Front. Microbiol. 2019;9:3301. doi: 10.3389/fmicb.2018.03301. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 158.Lin M.-F., Lin Y.-Y., Lan C.-Y. Contribution of EmrAB efflux pumps to colistin resistance in Acinetobacter baumannii. J. Microbiol. 2017;55:130–136. doi: 10.1007/s12275-017-6408-5. [DOI] [PubMed] [Google Scholar]
- 159.Farshadzadeh Z., Taheri B., Rahimi S., Shoja S., Pourhajibagher M., Haghighi M.A., Bahador A. Growth rate and biofilm formation ability of clinical and laboratory-evolved colistin-resistant strains of Acinetobacter baumannii. Front. Microbiol. 2018;9:153. doi: 10.3389/fmicb.2018.00153. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 160.Martínez-Guitián M., Vázquez-Ucha J.C., Álvarez-Fraga L., Conde-Pérez K., Bou G., Poza M., Beceiro A. Antisense inhibition of lpxB gene expression in Acinetobacter baumannii by peptide–PNA conjugates and synergy with colistin. J. Antimicrob. Chemother. 2020;75:51–59. doi: 10.1093/jac/dkz409. [DOI] [PubMed] [Google Scholar]
- 161.Mussi M.A., Limansky A.S., Relling V., Ravasi P., Arakaki A., Actis L.A., Viale A.M. Horizontal gene transfer and assortative recombination within the Acinetobacter baumannii clinical population provide genetic diversity at the single carO gene, encoding a major outer membrane protein channel. J. Bacteriol. 2011;193:4736–4748. doi: 10.1128/JB.01533-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 162.Harding C.M., Hennon S.W., Feldman M.F. Uncovering the mechanisms of Acinetobacter baumannii virulence. Nat. Rev. Microbiol. 2018;16:91–102. doi: 10.1038/nrmicro.2017.148. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 163.Tomaras A.P., Dorsey C.W., Edelmann R.E., Actis L.A. Attachment to and biofilm formation on abiotic surfaces by Acinetobacter baumannii: Involvement of a novel chaperone-usher pili assembly system. Microbiology. 2003;149:3473–3484. doi: 10.1099/mic.0.26541-0. [DOI] [PubMed] [Google Scholar]
- 164.Piepenbrink K.H., Lillehoj E., Harding C.M., Labonte J.W., Zuo X., Rapp C.A., Munson R.S., Goldblum S.E., Feldman M.F., Gray J.J. Structural diversity in the type IV pili of multidrug-resistant Acinetobacter. J. Biol. Chem. 2016;291:22924–22935. doi: 10.1074/jbc.M116.751099. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 165.Behzadi P., Behzadi E. Uropathogenic Escherichia coli: An ideal resource for DNA microarray probe designing; Proceedings of the Bioinformatics and Biomedical Engineering: 5th International Work-Conference, IWBBIO 2017; Granada, Spain. 26–28 April 2017; pp. 12–19. Proceedings, Part II 5. [Google Scholar]
- 166.Hesse L.E., Lonergan Z.R., Beavers W.N., Skaar E.P. The Acinetobacter baumannii Znu system overcomes host-imposed nutrient zinc limitation. Infect. Immun. 2019;87:10-1128. doi: 10.1128/IAI.00746-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 167.Harding C.M., Pulido M.R., Di Venanzio G., Kinsella R.L., Webb A.I., Scott N.E., Pachón J., Feldman M.F. Pathogenic Acinetobacter species have a functional type I secretion system and contact-dependent inhibition systems. J. Biol. Chem. 2017;292:9075–9087. doi: 10.1074/jbc.M117.781575. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 168.Cianfanelli F.R., Monlezun L., Coulthurst S.J. Aim, load, fire: The type VI secretion system, a bacterial nanoweapon. Trends Microbiol. 2016;24:51–62. doi: 10.1016/j.tim.2015.10.005. [DOI] [PubMed] [Google Scholar]
- 169.Cianfanelli F.R., Alcoforado Diniz J., Guo M., De Cesare V., Trost M., Coulthurst S.J. VgrG and PAAR proteins define distinct versions of a functional type VI secretion system. PLoS Pathog. 2016;12:e1005735. doi: 10.1371/journal.ppat.1005735. [DOI] [PMC free article] [PubMed] [Google Scholar]